MAPK8 and lung carcinoma: JNK is a proapoptotic protein kinase that leads to the inhibition of antiapoptotic BCL-2 proteins by phosphorylating them and, thus, inducing cell death in HEK 293T, lung cancer (A549) cells [49,50], hepatocytes [51], and beta-cells [52].